Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|May 18, 2019
B7-H3 Immune Checkpoint Protein in Human CancerKarine Flem-Karlsen, Øystein Fodstad, Caroline E Nunes-Xavier
Gynecologic Oncology|November 19, 2018
Soluble AXL is ubiquitously present in malignant serous effusionsKarine Flem Karlsen, Erin McFadden, Vivi Ann Flørenes, et al.
Trends in Cancer|June 5, 2018
B7-H3 in Cancer - Beyond Immune RegulationKarine Flem-Karlsen, Øystein Fodstad, Ming Tan, et al.
Pigment Cell & Melanoma Research|May 18, 2017
Immunoregulatory protein B7-H3 promotes growth and decreases sensitivity to therapy in metastatic melanoma cellsKarine Flem-Karlsen, Christina Tekle, Yvonne Andersson, et al.
Scientific Reports|April 11, 2019
p38 MAPK activation through B7-H3-mediated DUSP10 repression promotes chemoresistanceKarine Flem-Karlsen, Christina Tekle, Tove Øyjord, et al.
Plos One|January 10, 2020
Soluble AXL as a marker of disease progression and survival in melanomaKarine Flem-Karlsen, Marta Nyakas, Inger Nina Farstad, et al.
Frontiers in Oncology|June 13, 2022
Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate CancerCaroline E Nunes-Xavier, Janire Mingo, Maite Emaldi, et al.
Oncotarget|January 16, 2016
Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitorsCaroline E Nunes-Xavier, Karine Flem Karlsen, Christina Tekle, et al.
Molecular Cancer Therapeutics|December 25, 2019
Targeting AXL and the DNA Damage Response Pathway as a Novel Therapeutic Strategy in MelanomaKarine Flem-Karlsen, Erin McFadden, Nasrin Omar, et al.
Cancer Research|August 19, 2025
Cytotoxic CD8+ T Cells Downregulate GPX4 to Promote Ferroptosis in Melanoma that Drives Antitumor ImmunityKarine Flem-Karlsen, Ronan Talty, Meaghan K McGeary, et al.
Pageof 2